LMR Partners »

Eyepoint Pharmaceuticals shares owned by LMR Partners

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by LMR Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 106k 23.11
2023-09-30 $718k 90k 7.99
2021-03-31 $148k 15k 10.14

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr National Mun Etf Call Option (MUB)
Pdd Holdings Note10/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Tripadvisor Put Option (TRIP)
Cytokinetics Note 4.000%11/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Advanced Micro Devices Call Option (AMD)
Dish Network Corporation Note 3.375% 8/1 (Principal)
BP Sponsored Adr (BP)
NVIDIA Corporation (NVDA)
United States Steel Corporation (X)
Carnival Corp Common Stock Put Option (CCL)

View all positions for LMR Partners

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
Susquehanna International
First Turn Management
UBS Group

View all funds holding Eyepoint Pharmaceuticals